# Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

Study · id `cardio:ct-nct02499185` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02499185](<https://clinicaltrials.gov/study/NCT02499185>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02499185

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; High blood pressure; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02499185. Non-randomized; no masking; primary purpose diagnostic. Start 2015-04-01 (actual); primary completion 2017-07-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02499185, source copy `cardio:ctgov-nct02499185-2018-10-15`, retrieved 2026-10-26)
- Started: 2015-04-01 (actual) (ClinicalTrials.gov record NCT02499185, source copy `cardio:ctgov-nct02499185-2018-10-15`, retrieved 2026-10-26)
- Primary completion: 2017-07-31 (actual) (ClinicalTrials.gov record NCT02499185, source copy `cardio:ctgov-nct02499185-2018-10-15`, retrieved 2026-10-26)
- Completion: 2017-08-31 (actual) (ClinicalTrials.gov record NCT02499185, source copy `cardio:ctgov-nct02499185-2018-10-15`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT02499185, source copy `cardio:ctgov-nct02499185-2018-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02499185-2018-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients
- Condition: Acute Kidney Injury
- Condition: Arterial Hypertension
- Condition: Obesity
- Condition: Cardio Vascular Disease
- Condition: Diabetes Mellitus
- Condition: Chronic Liver Disease
- Condition: Hypercholesterolemia
- Intervention (Device): Nephro Check Test
- Intervention (Other): serum creatinine measurement
- Lead sponsor: Universitair Ziekenhuis Brussel
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Universitair Ziekenhuis Brussel (`cardio:org-universitair-ziekenhuis-brussel`)

## Provenance

Content hash: 86fff4efbef60ee9c65353a41dc09f0ba1df6f3798ba9affca99eb2ae295415e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
